<?xml version="1.0" encoding="UTF-8"?>
<results title="virus">
 <result pre="not comply with these terms. Abstract Infectious diseases caused by" exact="human immunodeficiency virus" post="(HIV) and other highly pathogenic enveloped viruses, have threatened"/>
 <result pre="important enveloped viruses, including HIV, influenza virus, Zika virus (ZIKV)," exact="dengue virus" post="(DENV), and herpes simplex virus (HSV), and the potential"/>
 <result pre="comprised of a variety of human pathogens, including DENV, ZIKV," exact="yellow fever virus" post="(YFV), West Nile virus (WNV), and so on (Kuno"/>
 <result pre="It was also effective against some other flaviviruses, such as" exact="yellow fever virus" post="(YFV) (Lok et al., 2012). Further studies of its"/>
 <result pre="simplex virus types 1 and 2 (HSV-1 and HSV-2) and" exact="varicella-zoster virus" post="(VZV) are human pathogens, which routinely infect humans (Roizman"/>
 <result pre="necrosis factor (TNF) receptor family, herpesvirus entry mediator (HVEM); the" exact="poliovirus" post="receptor family, including nectin-1 and nectin-2, belonging to the"/>
 <result pre="Chemother.53987â€&quot;996. 10.1128/AAC.00793-0819104014 AlhootM. A.RathinamA. K.WangS. M.ManikamR.SekaranS. D. (2013). Inhibition of" exact="dengue virus" post="entry into target cells using synthetic antiviral peptides.Int. J."/>
 <result pre="A.et al. (2010). Structural optimization and de novo design of" exact="dengue virus" post="entry inhibitory peptides.PLoS Negl. Trop. Dis.4:e72110.1371/journal.pntd.0000721 CuiL.ZouP.ChenE.YaoH.ZhengH.WangQ.et al. (2017)."/>
 <result pre="(2017). Visual and motor deficits in grown-up mice with congenital" exact="zika virus" post="infection.EBioMedicine20193â€&quot;201. 10.1016/j.ebiom.2017.04.02928583742 CulshawA.MongkolsapayaJ.ScreatonG. (2018). The immunology of Zika Virus.F1000Res.7:20310.12688/f1000research.12271.1"/>
 <result pre="concentrations of recombinant soluble CD4 are required to neutralize primary" exact="human immunodeficiency virus" post="type 1 isolates.Proc. Natl. Acad. Sci. U.S.A.876574â€&quot;6578. 10.1073/pnas.87.17.65742395859 DavisonA."/>
 <result pre="with HIV-1.Nat. Med.111170â€&quot;1172. 10.1038/nm131916205738 FerrerM.HarrisonS. C. (1999). Peptide ligands to" exact="human immunodeficiency virus" post="type 1 gp120 identified from phage display libraries.J. Virol.735795â€&quot;5802.10364331"/>
 <result pre="(1998). CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary" exact="human immunodeficiency virus" post="type 1 isolates.J. Virol.723475â€&quot;3478.9525686 GompelsU.MinsonA. (1986). The properties and"/>
 <result pre="Microbe17295â€&quot;300. 10.1016/j.chom.2015.02.01225766291 HrobowskiY. M.GarryR. F.MichaelS. F. (2005). Peptide inhibitors of" exact="dengue virus" post="and West Nile virus infectivity.Virol. J.2:4910.1186/1743-422X-2-49 HuertaV.ChineaG.FleitasN.SarriaM.SanchezJ.ToledoP.et al. (2008)."/>
 <result pre="the interaction of domain III of the envelope protein of" exact="dengue virus" post="with putative receptors from CHO cells.Virus Res.137225â€&quot;234. 10.1016/j.virusres.2008.07.02218723056 HungJ."/>
 <result pre="C.ChangW. (2004). An external loop region of domain III of" exact="dengue virus" post="type 2 envelope protein is involved in serotype-specific binding"/>
 <result pre="JacobsonJ. M.IsraelR. J.LowyI.OstrowN. A.VassilatosL. S.BarishM.et al. (2004). Treatment of advanced" exact="human immunodeficiency virus" post="type 1 disease with the viral entry inhibitor PRO"/>
 <result pre="al. (2000). Single-dose safety, pharmacology, and antiviral activity of the" exact="human immunodeficiency virus" post="(HIV) type 1 entry inhibitor PRO 542 in HIV-infected"/>
 <result pre="University Press). KleinD. E.ChoiJ. L.HarrisonS. C. (2013). Structure of a" exact="dengue virus" post="envelope protein late-stage fusion intermediate.J. Virol.872287â€&quot;2293. 10.1128/JVI.02957-1223236058 KrummenacherC.SupekarV. M.WhitbeckJ."/>
 <result pre="LokS. M.CostinJ. M.HrobowskiY. M.HoffmannA. R.RoweD. K.KukkaroP.et al. (2012). Release of" exact="dengue virus" post="genome induced by a peptide inhibitor.PLoS One7:e5099510.1371/journal.pone.0050995 LuL.PanC.LiY.LuH.HeW.JiangS. (2012)."/>
 <result pre="HIV-1 paradigm.Retrovirology5:11110.1186/1742-4690-5-111 ModisY.OgataS.ClementsD.HarrisonS. C. (2003). A ligand-binding pocket in the" exact="dengue virus" post="envelope glycoprotein.Proc. Natl. Acad. Sci. U.S.A.1006986â€&quot;6991. 10.1073/pnas.083219310012759475 MoirS.ChunT. W.FauciA."/>
 <result pre="S. (1993). Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of" exact="human immunodeficiency virus" post="type 1 (HIV-1) infectivity and their relation to primary"/>
 <result pre="PanC.CaiL.LuH.QiZ.JiangS. (2009). Combinations of the first and next generations of" exact="human immunodeficiency virus" post="(HIV) fusion inhibitors exhibit a highly potent synergistic effect"/>
 <result pre="1 strains.J. Virol.837862â€&quot;7872. 10.1128/JVI.00168-0919493996 PanyaA.BangphoomiK.ChoowongkomonK.YenchitsomanusP. T. (2014). Peptide inhibitors against" exact="dengue virus" post="infection.Chem. Biol. Drug Des.84148â€&quot;157. 10.1111/cbdd.1230924612829 PanyaA.SawasdeeN.JunkingM.SrisawatC.ChoowongkomonK.YenchitsomanusP. T. (2015). A"/>
 <result pre="ectodomain region of DENV membrane (M) protein with activity against" exact="dengue virus" post="infection.Chem. Biol. Drug Des.861093â€&quot;1104. 10.1111/cbdd.1257625891143 ParajuliB.AcharyaK.BachH. C.ParajuliB.ZhangS.SmithA. B.et al."/>
 <result pre="J.475931â€&quot;957. 10.1042/BCJ2017066229343613 ParajuliB.AcharyaK.YuR.NgoB.RashadA. A.AbramsC. F.et al. (2016). Lytic inactivation of" exact="human immunodeficiency virus" post="by dual engagement of gp120 and gp41 domains in"/>
 <result pre="Mol. Biol.16265â€&quot;273. 10.1038/nsmb.156619234466 SullivanN.SunY.BinleyJ.LeeJ.BarbasC. F.IIIParrenP. W.et al. (1998). Determinants of" exact="human immunodeficiency virus" post="type 1 envelope glycoprotein activation by soluble CD4 and"/>
 <result pre="review.Chem. Pharm. Bull.66191â€&quot;206. 10.1248/cpb.c17-0079429491253 TrauneckerA.LukeW.KarjalainenK. (1988). Soluble CD4 molecules neutralize" exact="human immunodeficiency virus" post="type 1.Nature33184â€&quot;86. 10.1038/331084a02829024 TrkolaA.PomalesA. B.YuanH.KorberB.MaddonP. J.AllawayG. P.et al. (1995)."/>
 <result pre="J.AllawayG. P.et al. (1995). Cross-clade neutralization of primary isolates of" exact="human immunodeficiency virus" post="type 1 by human monoclonal antibodies and tetrameric CD4-IgG.J."/>
 <result pre="J. (1994). Peptides corresponding to a predictive alpha-helical domain of" exact="human immunodeficiency virus" post="type 1 gp41 are potent inhibitors of virus infection.Proc."/>
 <result pre="10.1080/13543784.2017.1269170 ZhangX.GeP.YuX.BrannanJ. M.BiG.ZhangQ.et al. (2013). Cryo-EM structure of the mature" exact="dengue virus" post="at 3.5-A resolution.Nat. Struct. Mol. Biol.20105â€&quot;110. 10.1038/nsmb.246323241927"/>
</results>
